Speaker illustration

Doctor Peter Weeke

Rigshospitalet, Copenhagen (Denmark)

Member of:

European Society of Cardiology

Long-term proarrhythmic pharmacotherapy among patients with congenital long QT syndrome and risk of arrhythmia and mortality

Date: 11 May 2019

Journal: European Heart Journal


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb